Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Innovations (Philadelphia, Pa.)
|
April 6, 2018
CC1 Emergent Endovascular Repair of a Ruptured Descending Thoracic Aortic Aneurysm in an Arresting Patient
Warren Naselsky, Charles F Evans, Brody Wehman, et al.
Annals of Thoracic Surgery Short Reports
|
December 22, 2025
Factors Associated With Next-Day Discharge After Pulmonary Lobectomy
Anuj Shah, Ray Chihara, Warren Naselsky, et al.
Annals of Thoracic Surgery Short Reports
|
December 22, 2025
Robot-Assisted Laparoscopic Repair of Pericardial Hernia in a Heart Transplant Patient
Samar Semaan, Jerry Xiao, Ray Chihara, et al.
The Annals of Thoracic Surgery
|
November 8, 2025
A Standardized Remediation Approach for the Integrated Cardiothoracic Surgery Trainee: Review of Current Paradigms and Suggested Strategies
Jeremiah Hutson, Riya Aggarwal, Justin Robinson, et al.
Oncogenesis
|
October 24, 2021
ACTL6A suppresses p21<sup>Cip1</sup> tumor suppressor expression to maintain an aggressive mesothelioma cancer cell phenotype
Suruchi Shrestha, Gautam Adhikary, Warren Naselsky, et al.
Annals of Thoracic Surgery Short Reports
|
June 10, 2026
Intercostal Nerve Cryoablation and Pain Outcomes in Robotic Lung Surgery
Ray Chihara, Zoe Lichtenberg, Elsie Rizk, et al.
Molecular Carcinogenesis
|
October 26, 2022
Sulforaphane inhibits CD44v6/YAP1/TEAD signaling to suppress the cancer phenotype
Xi Chen, Gautam Adhikary, Emily Ma, et al.
The Annals of Thoracic Surgery
|
February 5, 2021
Limited Left Thoracoscopic Sympathectomy Effectively Silences Refractory Electrical Storm
Eric M Krause, Jason Appelbaum, Warren Naselsky, et al.
Molecular Cancer Research : MCR
|
October 1, 2021
Transglutaminase 2 Maintains Hepatocyte Growth Factor Signaling to Enhance the Cancer Cell Phenotype
Xi Chen, Gautam Adhikary, Suruchi Shrestha, et al.
Molecular Carcinogenesis
|
July 18, 2022
The transglutaminase 2 cancer cell survival factor maintains mTOR activity to drive an aggressive cancer phenotype
Xi Chen, Gautam Adhikary, John J Newland, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Innovations (Philadelphia, Pa.)
|
April 6, 2018
CC1 Emergent Endovascular Repair of a Ruptured Descending Thoracic Aortic Aneurysm in an Arresting Patient
Warren Naselsky, Charles F Evans, Brody Wehman, et al.
Annals of Thoracic Surgery Short Reports
|
December 22, 2025
Factors Associated With Next-Day Discharge After Pulmonary Lobectomy
Anuj Shah, Ray Chihara, Warren Naselsky, et al.
Annals of Thoracic Surgery Short Reports
|
December 22, 2025
Robot-Assisted Laparoscopic Repair of Pericardial Hernia in a Heart Transplant Patient
Samar Semaan, Jerry Xiao, Ray Chihara, et al.
The Annals of Thoracic Surgery
|
November 8, 2025
A Standardized Remediation Approach for the Integrated Cardiothoracic Surgery Trainee: Review of Current Paradigms and Suggested Strategies
Jeremiah Hutson, Riya Aggarwal, Justin Robinson, et al.
Oncogenesis
|
October 24, 2021
ACTL6A suppresses p21<sup>Cip1</sup> tumor suppressor expression to maintain an aggressive mesothelioma cancer cell phenotype
Suruchi Shrestha, Gautam Adhikary, Warren Naselsky, et al.
Annals of Thoracic Surgery Short Reports
|
June 10, 2026
Intercostal Nerve Cryoablation and Pain Outcomes in Robotic Lung Surgery
Ray Chihara, Zoe Lichtenberg, Elsie Rizk, et al.
Molecular Carcinogenesis
|
October 26, 2022
Sulforaphane inhibits CD44v6/YAP1/TEAD signaling to suppress the cancer phenotype
Xi Chen, Gautam Adhikary, Emily Ma, et al.
The Annals of Thoracic Surgery
|
February 5, 2021
Limited Left Thoracoscopic Sympathectomy Effectively Silences Refractory Electrical Storm
Eric M Krause, Jason Appelbaum, Warren Naselsky, et al.
Molecular Cancer Research : MCR
|
October 1, 2021
Transglutaminase 2 Maintains Hepatocyte Growth Factor Signaling to Enhance the Cancer Cell Phenotype
Xi Chen, Gautam Adhikary, Suruchi Shrestha, et al.
Molecular Carcinogenesis
|
July 18, 2022
The transglutaminase 2 cancer cell survival factor maintains mTOR activity to drive an aggressive cancer phenotype
Xi Chen, Gautam Adhikary, John J Newland, et al.
Page
of 2